|Dr. George Adams||CEO & Director||186.37k||N/A||1951|
|Mr. Desmond Hirson||Pres||N/A||N/A||N/A|
|Ms. Ellen Briant||CFO & Corp. Sec.||81.19k||N/A||N/A|
|Dr. Alvira Macanovic Ph.D.||VP of Devel. & Operations||N/A||N/A||N/A|
|Mr. Jim Graba||Application Specialist & Chief Trainer||N/A||N/A||N/A|
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
VentriPoint Diagnostics Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.